Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00054262 · ClinicalTrials.gov registry record · Phase 2
T900607 in Treating Patients With Unresectable Liver Cancer
A Phase 2 study, sponsored by University Hospitals Seidman Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00054262 is a Phase 2 study that has completed, run by University Hospitals Seidman Cancer Center.
The verdict
NCT00054262, a Phase 2 study, has completed, sponsored by University Hospitals Seidman Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of T900607 in treating patients who have unresectable liver cancer.
Interventions
- DRUG T900607
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-11 |
| Est. Completion | 2010-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00054262
The ClinicalTrials.gov registry entry for NCT00054262 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University Hospitals Seidman Cancer Center, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which T900607 is the first listed.
NCT00054262 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00054262 about?
NCT00054262 is a clinical study titled "T900607 in Treating Patients With Unresectable Liver Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of T900607 in treating patients who have unresectable liver cancer.
What is the current status of trial NCT00054262?
This trial is currently completed. It is a Phase 2 study. The study started on 2002-11. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00054262?
The interventions under investigation include: T900607 (DRUG).
Who is sponsoring clinical trial NCT00054262?
This trial is sponsored by University Hospitals Seidman Cancer Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.